Plotkin's Vaccines

De (autor) , , ,
Notă GoodReads:
en Limba Engleză Carte Hardback – 26 Jun 2017

From the development of each vaccine to its use in reducing disease, Plotkin's Vaccines, 7th Edition, provides the expert information you need to provide optimal care to your patients. This award-winning text offers a complete understanding of each disease, as well as the latest knowledge of both existing vaccines and those currently in research and development. Described by Bill Gates as "an indispensable guide to the enhancement of the well-being of our world," Plotkin's Vaccines is a must-have reference for current, authoritative information in this fast-moving field.

Citește tot Restrânge

Preț: 146685 lei

Preț vechi: 154406 lei

Puncte Express: 2200

Preț estimativ în valută:
29234 32376$ 24573£

Carte disponibilă

Livrare economică 23-28 decembrie

Preluare comenzi: 021 569.72.76


ISBN-13: 9780323357616
ISBN-10: 032335761X
Pagini: 1720
Ilustrații: Approx. 600 illustrations (600 in full color)
Dimensiuni: 228 x 294 x 57 mm
Greutate: 3.58 kg
Ediția: 7
Editura: Elsevier


Section 1: General Aspects of Vaccination
1. A Short History of Vaccination
2. Vaccine Immunology
3. Correlates of Protection
4. The Vaccine Industry
5. Vaccine Manufacturing
6. Evolution of Adjuvants Across the Centuries
7. Vaccine Additives and Manufacturing Residuals in Vaccines Licensed in the United States
8. Passive Immunization
9. General Immunization Practices
Section 2: Licensed Vaccines and Vaccines in Development
10. Adenovirus Vaccines
11. Anthrax Vaccines
12. Biodefense and Special Pathogen Vaccines
13. Cancer Vaccines
14. Cholera Vaccines
15. Combination Vaccines
16. Cytomegalovirus Vaccines
17. Dengue Vaccines
18. Diarrhea Caused by Bacteria
19. Diphtheria Toxoid
20. Ebola Vaccines
21. Enterovirus 71
22. Epstein-Barr Virus Vaccines
23. Haemophilus influenzae Type b Vaccines
24. Hepatitis A Vaccines
25. Hepatitis B Vaccines
26. Hepatitis C Vaccines
27. Hepatitis E Vaccines
28. Herpes Simplex Virus Vaccines
29. Human Immunodeficiency Virus Vaccines
30. Human Papillomavirus Vaccines
31. Inactivated Influenza Vaccines
32. Influenza Vaccine-Live
33. Japanese Encephalitis Vaccines
34. Lyme Disease Vaccines
35. Malaria Vaccines
36. Maternal Immunization
37. Measles Vaccines
38. Meningococcal Capsular Group A, C, W, and Y Conjugate Vaccines
39. Meningococcal Capsular Group B Vaccines
40. Mumps Vaccines
41. Noninfectious Disease Vaccines
42. Norovirus Vaccines
43. Parasitic Disease Vaccines
44. Pertussis Vaccines
45. Plague Vaccines
46. Pneumococcal Conjugate Vaccine and Pneumococcal Common Protein Vaccines
47. Pneumococcal Polysaccharide Vaccines
48. Poliovirus Vaccine-Inactivated
49. Poliovirus Vaccine-Live
50. Rabies Vaccines
51. Respiratory Syncytial Virus Vaccines
52. Rotavirus Vaccines
53. Rubella Vaccines
54. Smallpox and Vaccinia
55. Staphylococcus aureus Vaccines
56. Streptococcus Group A Vaccines
57. Streptococcus Group B Vaccines
58. Tetanus Toxoid
59. Tickborne Encephalitis Vaccines
60. Tuberculosis Vaccines
61. Typhoid Fever Vaccines
62. Varicella Vaccines
63. Yellow Fever Vaccines
64. Zika Virus
65. Zoster Vaccines
Section 3: New Technologies
66. Technologies for Making New Vaccines
67. Development of Gene-Based Vectors for Immunization
68. Technologies to Improve Immunization
Section 4: Vaccination of Special Groups
69. Vaccination of Immunocompromised Hosts
70. Vaccination of Human Immunodeficiency Virus-Infected Persons
71. Vaccines for International Travel
72. Vaccines for Healthcare Personnel
Section 5: Public Health and Regulatory Issues
73. Immunization in the United States
74. Immunization in Europe
75. Immunization in the Asia-Pacific Region
76. Immunization in Developing Countries
77. Community Protection
78. Economic Analyses of Vaccine Policies
79. Regulation and Testing of Vaccines
80. Regulation of Vaccines in Europe
81. Regulation of Vaccines in Low- and Middle-Income Countries
82. Vaccine Safety
83. Legal Issues
84. Ethics
Appendix: Websites and Applications for Mobile Devices with Information about Immunization